Skip to main content
. 2014 Nov 8;15(6):188–203. doi: 10.1120/jacmp.v15i6.4978

Table 2.

Comparison between conventional 3D dose calculation and path‐integrated 4D cumulative dose calculation in target volumes; dose in Gy. HI is dimensionless and 3D refers to the dose for 3DREF.

Lesion Target (volume in cm3)
Dmean
(3D / 4D)
BEDmean
(3D / 4D)
D2
(3D / 4D)
D98
(3D / 4D)
HI (3D / 4D) HI3D/HI4D (=HI3D/4D%)
A GTV (22.7) 45.3 / 44.9 79.5 / 78.5 46.8 / 46.7 43.1 / 42.7 1.08 / 1.09 99.1
ITV (31.1) 45.1 / 44.7 79.0 / 78.0 46.7 / 46.7 42.6 / 38.9 1.10 / 1.20 91.7
PTV (66.4) 44.0 / 43.4 76.3 / 74.8 46.7 / 46.7 36.8 / 30.9 1.27 / 1.51 84.1
B GTV (12.4) 42.7 / 40.4 73.1 / 67.6 43.4 / 43.2 41.1 / 39.8 1.06 / 1.08 98.2
ITV (17.9) 42.1 / 39.0 71.6 / 64.4 43.3 / 43.2 36.9 / 33.8 1.17 / 1.28 91.4
PTV (39.3) 41.1 / 37.8 69.2 / 61.7 43.3 / 43.2 31.7 / 26.4 1.37 / 1.64 83.5
C GTV (54.5) 48.2 / 47.8 86.9 / 85.9 50.2 / 49.8 46.1 / 45.6 1.08 / 1.09 99.7
ITV (87.0) 48.0 / 47.4 86.4 / 84.8 50.2 / 49.8 44.7 / 44.1 1.12 / 1.13 99.1
PTV (168.7) 47.4 / 46.3 84.8 / 82.0 50.1 / 49.8 42.8 / 36.6 1.17 / 1.36 86.0
D GTV (6.68) 55.3 / 55.0 116.5 / 115.5 55.8 / 55.6 54.3 / 53.9 1.02 / 1.03 99.6
ITV (21.28) 54.8 / 54.4 114.9 / 113.6 55.7 / 55.5 53.0 / 52.2 1.05 / 1.06 98.8
PTV (71.36) 52.7 / 50.7 108.2 / 102.1 55.6 / 55.4 46.3 / 35.3 1.20 / 1.57 76.5
E GTV (86.16) 46.2 / 45.0 81.8 / 78.8 46.7 / 45.9 43.8 / 41.9 1.07 / 1.08 99.1
ITV (100.5) 46.0 / 44.8 81.3 / 78.3 46.6 / 45.8 43.2 / 41.2 1.08 / 1.11 97.0
PTV (187.24) 44.3 / 42.4 77.0 / 72.4 46.3 / 45.4 38.2 / 31.0 1.21 / 1.46 82.8

3D = three‐dimensional dose calculation; 4D = four‐dimensional dose calculation; Dmean=mean dose; BEDmean=biologically effective mean dose; D2=2%nearmaximum dose; D98=98%nearminimum dose; HI = homogeneity index (the ratio of D2 to D98,D2/D98); HI3D/4D% = the percentage ratio of HI for 3D to 4D (HI3D/HI4D). All doses in Gy.